The number and ASR of deaths for <i>Klebsiella pneumoniae</i>-related LRI burden in 1990 and 2021, and its trends from 1990 to 2021. by Juanjuan Li (399633)

The number and ASR of DALYs for <i>Klebsiella pneumoniae</i>-related LRI burden in 1990 and 2021, and its trends from 1990 to 2021. by Juanjuan Li (399633)

The trends in numbers of DALYs and deaths for <i><i>Klebsiella pneumoniae</i></i> associated LRI burden from 1990 to 2021. DALYs, disability-adjusted life years. by Juanjuan Li (399633)

Global and national estimates of deaths due to <i>Klebsiella pneumoniae</i>-associated lower respiratory infections in 1990 and 2021. by Juanjuan Li (399633)

Global and national estimates of disability-adjusted life years (DALYs) due to <i>Klebsiella pneumoniae</i>-associated lower respiratory infections in 1990 and 2021. by Juanjuan Li (399633)

Correlation between Estimated Annual Percentage Change (EAPC) of <i><i>Klebsiella pneumoniae</i></i> associated lower respiratory infection (LRI) and death rates, and Socio-demogra... by Juanjuan Li (399633)

Raw data. by Pingling Kwok (14896191)

Variation of MLR of concrete under three curing conditions after F–T: (a) standard curing; (b) 5 °C curing; (c) −3 °C curing. by YongHe Liu (20477123)

A Novel Type of PSMA-Targeting Ligands via β‑Branched Aromatic α‑Amino Acid Modification, Bearing Enhanced Tumor Targeting and Reduced Renal Toxicity by Zong-Xiao Liu (22177765)

“…With average renal uptake of less than 10%ID/g, as opposed to 25%ID/g for [⁶⁸Ga]Ga-<b>PSMA-617</b>, this substantial decrease in renal accumulation translates to a significantly improved safety profile by minimizing nephrotoxic risks. …”

A Novel Type of PSMA-Targeting Ligands via β‑Branched Aromatic α‑Amino Acid Modification, Bearing Enhanced Tumor Targeting and Reduced Renal Toxicity by Zong-Xiao Liu (22177765)

“…With average renal uptake of less than 10%ID/g, as opposed to 25%ID/g for [⁶⁸Ga]Ga-<b>PSMA-617</b>, this substantial decrease in renal accumulation translates to a significantly improved safety profile by minimizing nephrotoxic risks. …”

Meta-analysis revealed a positive association between GSRS and TNF-α signaling across 8 KIRC cohorts. by Yu Zhang (12946)

Data Sheet 1_Secretoneurin plasma levels are decreased after catheter ablation for atrial fibrillation—patients with AF produce lower SN levels than healthy individuals: the SAFE r... by Jiří Plášek (21805048)

“…Background<p>Secretoneurin (SN) is a neuropeptide that counterbalances disorders of cell calcium cycling via calmodulin and thus may be involved in arrhythmogenesis. …”

Primary monocytes at 1 x 10⁶ cells were seeded in a flask and supplemented with RPMI 1640 + GM-CSF + IL-4 and incubated at 37°C for 6 days for monocyte to macrophage tra... by Janani Madhuravasal Krishnan (19736002)

Proportion of time spent in the Start Room or Avoidance Room or showing a behaviour (Stimulus Contact) presented across stimuli and separately for female (n = 10) and male (n = 10)... by Sara Hintze (3216885)

Initial participants by wave*. by Yeo Ju Sohn (18536198)

“…<div><p>Background</p><p>Diabetes mellitus (DM) is a significant public health concern, particularly in the elderly population. …”

General characteristics of research participants. by Yeo Ju Sohn (18536198)

“…<div><p>Background</p><p>Diabetes mellitus (DM) is a significant public health concern, particularly in the elderly population. …”

Singling Out the Electrochemiluminescence Profile in Microelectrode Arrays by Chiara Mariani (20716841)

“…In contrast, a significant narrowing of the ECL profile was observed on Au, indicative of a transition from a catalytic to an oxidative–reductive pathway. …”

Singling Out the Electrochemiluminescence Profile in Microelectrode Arrays by Chiara Mariani (20716841)

“…In contrast, a significant narrowing of the ECL profile was observed on Au, indicative of a transition from a catalytic to an oxidative–reductive pathway. …”

Clinical data of the control and CoA cases in our cohort. by Inmaculada Villanueva-Baxarias (21454246)

Table2_Significant nocturnal wakefulness after sleep onset in metabolic dysfunction–associated steatotic liver disease.DOCX by Sofia Schaeffer (20379954)

“…<p>Metabolic dysfunction–associated steatotic liver disease (MASLD) is a multisystemic disease with a multifactorial pathogenesis involving dietary, environmental, and genetic factors. …”